blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2100895

EP2100895 - TRICYCLIC COMPOUND AND MEDICAL USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.01.2013
Database last updated on 27.07.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1, Doshomachi 4-chome Chuo-ku
Osaka- shi, Osaka 541-0045 / JP
[2009/38]
Inventor(s)01 / UCHIKAWA, Osamu
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
26-1, Muraoka-Higashi 2-chome
Fujisawa Kanagawa 251-0012 / JP
02 / KOIKE, Tatsuki
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
26-1, Muraoka-Higashi 2-chome
Fujisawa Kanagawa 251-0012 / JP
03 / TAKAI, Takafumi
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
26-1, Muraoka-Higashi 2-chome
Fujisawa Kanagawa 251-0012 / JP
04 / HOASHI, Yasutaka
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
26-1, Muraoka-Higashi 2-chome
Fujisawa Kanagawa 251-0012 / JP
 [2012/08]
Former [2009/38]01 / UCHIKAWA, Osamu
TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
02 / KOIKE, Tatsuki
TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
03 / TAKAI, Takafumi
TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
04 / HOASHI, Yasutaka
TAKEDA PHARMACEUTICAL COMPANY LIMITED 17-85, Jusohonmachi 2-chome Yodogawa-ku
Osaka-shi Osaka 532-8686 / JP
Representative(s)Jones, Nicholas Andrew, et al
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[N/P]
Former [2012/10]Jones, Nicholas Andrew, et al
Withers & Rogers LLP
4 More London Riverside
London
SE1 2AU / GB
Former [2009/38]Jones, Nicholas Andrew, et al
Withers & Rogers LLP Goldings House 2 Hays Lane
GB-London SE1 2HW / GB
Application number, filing date07850267.107.12.2007
[2009/38]
WO2007JP73680
Priority number, dateJP2006033264708.12.2006         Original published format: JP 2006332647
[2009/38]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008069311
Date:12.06.2008
Language:JA
[2008/24]
Type: A1 Application with search report 
No.:EP2100895
Date:16.09.2009
Language:EN
[2009/38]
Type: B1 Patent specification 
No.:EP2100895
Date:07.03.2012
Language:EN
[2012/10]
Search report(s)International search report - published on:JP12.06.2008
(Supplementary) European search report - dispatched on:EP23.11.2009
ClassificationIPC:C07D491/147, A61K31/4355, A61K31/437, A61P25/20, C07D491/048
[2009/38]
CPC:
C07D491/04 (EP,US); C07D491/147 (KR); A61K31/4355 (KR);
A61P25/00 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P43/00 (EP); C07D491/048 (KR);
C07D491/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/38]
TitleGerman:TRICYCLISCHE VERBINDUNG UND DEREN MEDIZINISCHE VERWENDUNG[2009/38]
English:TRICYCLIC COMPOUND AND MEDICAL USE THEREOF[2009/38]
French:COMPOSÉ TRICYCLIQUE ET SON UTILISATION MÉDICALE[2009/38]
Entry into regional phase03.06.2009Translation filed 
03.06.2009National basic fee paid 
03.06.2009Search fee paid 
03.06.2009Designation fee(s) paid 
03.06.2009Examination fee paid 
Examination procedure03.06.2009Amendment by applicant (claims and/or description)
03.06.2009Examination requested  [2009/38]
16.02.2010Despatch of a communication from the examining division (Time limit: M06)
17.08.2010Reply to a communication from the examining division
02.12.2010Despatch of a communication from the examining division (Time limit: M04)
12.04.2011Reply to a communication from the examining division
27.09.2011Communication of intention to grant the patent
27.01.2012Fee for grant paid
27.01.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.02.2010
Opposition(s)10.12.2012No opposition filed within time limit [2013/07]
Fees paidRenewal fee
22.12.2009Renewal fee patent year 03
22.12.2010Renewal fee patent year 04
22.12.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.12.2007
AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
MT07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
TR07.03.2012
BG07.06.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
IE07.12.2012
LU07.12.2012
[2014/34]
Former [2014/27]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
MT07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
TR07.03.2012
BG07.06.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
IE07.12.2012
LU07.12.2012
Former [2014/21]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
MT07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
TR07.03.2012
BG07.06.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
IE07.12.2012
Former [2013/51]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
MT07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
BG07.06.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
IE07.12.2012
Former [2013/47]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
BG07.06.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
IE07.12.2012
Former [2013/33]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
BG07.06.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
Former [2013/22]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
GR08.06.2012
ES18.06.2012
IS07.07.2012
PT09.07.2012
Former [2013/11]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
IT07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
GR08.06.2012
IS07.07.2012
PT09.07.2012
Former [2013/08]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
DK07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
GR08.06.2012
IS07.07.2012
PT09.07.2012
Former [2013/07]AT07.03.2012
BE07.03.2012
CY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
GR08.06.2012
IS07.07.2012
PT09.07.2012
Former [2013/01]BE07.03.2012
CY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
GR08.06.2012
IS07.07.2012
PT09.07.2012
Former [2012/50]BE07.03.2012
CY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
SK07.03.2012
GR08.06.2012
IS07.07.2012
Former [2012/49]BE07.03.2012
CY07.03.2012
CZ07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
PL07.03.2012
RO07.03.2012
SE07.03.2012
SI07.03.2012
GR08.06.2012
IS07.07.2012
Former [2012/48]BE07.03.2012
CY07.03.2012
EE07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
SE07.03.2012
GR08.06.2012
Former [2012/46]BE07.03.2012
CY07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
GR08.06.2012
Former [2012/41]CY07.03.2012
FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
GR08.06.2012
Former [2012/39]FI07.03.2012
LT07.03.2012
LV07.03.2012
NL07.03.2012
GR08.06.2012
Former [2012/37]FI07.03.2012
LT07.03.2012
NL07.03.2012
GR08.06.2012
Former [2012/36]LT07.03.2012
NL07.03.2012
GR08.06.2012
Former [2012/35]LT07.03.2012
NL07.03.2012
Former [2012/34]LT07.03.2012
Documents cited:Search[DY]WO9732871  (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [DY] 1-17 * pages 1-10 *;
 [DY]WO2006027474  (SERVIER LAB [FR], et al) [DY] 1-17 * the whole document *;
 [DY]  - ELSNER J ET AL, "Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, vol. 14, no. 6, ISSN 0968-0896, (20060315), pages 1949 - 1958, (20060315), XP025133085 [DY] 1-17 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmc.2005.10.042
International search[A]JPH11152281  (TAKEDA CHEMICAL INDUSTRIES LTD);
 [A]  - BENCKOVA M. ET AL., "5-Aminofuro[3,2-c]pyridinium tosylates and substituted furo[3,2-c]pyridine N-oxides: synthesis and reactions", COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, (1999), vol. 64, no. 3, pages 539 - 547, XP008109245

DOI:   http://dx.doi.org/10.1135/cccc19990539
by applicantUS5633276
 WO9732871
 US5843986
 US5998461
 US6034239
 WO2004100947
 WO2006027474
 JP2006332647
    - ANN. N. Y. ACAD. SCI., (1994), vol. 719, pages 456 - 460
    - CLINICAL EXAMINATIONS, (1994), vol. 38, no. 11, pages 282 - 284
    - BIOORGANIC & MEDICINAL CHEMISTR, (2006), vol. 14, pages 1949 - 1958
    - BIOORGANIC & MEDICINAL CHEMISTRY, (2006), vol. 14, pages 1949 - 1958
    - THE METHOD DESCRIBED IN HETEROCYCLES, (1997), vol. 45, page 976
    - J. HETEROCYCLIC CHEM., (1971), vol. 8, page 57
    - J. HETEROCYCLIC CHEM., (1997), vol. 34, page 941
    - CHEM. PHARM. BULL., (1984), vol. 32, page 4914
    - HETEROCYCLES, (1997), vol. 45, page 976
    - TETRAHEDRON, (1989), vol. 45, page 803
    - TETRAHEDRON, (1988), vol. 44, page 2977
    - TETRAHEDRON, (1987), vol. 43, page 5145
    - SYNTH. COMMUN., (1990), vol. 20, page 1819
    - TETRAHEDRON LETT., (2000), vol. 41, page 4165
    - J. ORG. CHEM., (1973), vol. 38, page 1239
    - J. ORG. CHEM., (2003), vol. 68, page 7119
    - Jikken Kagaku Koza (Courses in Experimental Chemistry), vol. 20, pages 69 - 110
    - Jikken Kagaku Koza (Courses in Experimental Chemistry), vol. 23, pages 1 - 550
    - Jikken Kagaku Koza (Courses in Experimental Chemistry), vol. 22, pages 43 - 54
    - Shin Jikken Kagaku Koza (New Experimental Chemistry Course), vol. 14, pages 251 - 253
    - Jikken Kagaku Koza (Courses in Experimental Chemistry), vol. 19, pages 273 - 274
    - Shin Jikken Kagaku Koza (New Experimental Chemistry Course), (1977), vol. 14, 15
    - "IYAKUHIN no KAIHATSU", Design of Molecules, HIROKAWA SHOTEN, vol. 7, pages 163 - 198
    - BIOCHIM BIOPHYS ACTA, (1994), vol. 1219, no. 2, pages 251 - 259
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.